Differential hRad17 expression by histologic subtype of ovarian cancer
<p>Abstract</p> <p>Background</p> <p>In the search for unique ovarian cancer biomarkers, ovarian specific cDNA microarray analysis identified hRad17, a cell cycle checkpoint protein, as over-expressed in ovarian cancer. The aim of this study was to validate this express...
Main Authors: | Young Jennifer L, Koon E Colin, Kwong Joseph, Welch William R, Muto Michael G, Berkowitz Ross S, Mok Samuel C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Journal of Ovarian Research |
Online Access: | http://www.ovarianresearch.com/content/4/1/6 |
Similar Items
-
Localization of hRad9 in breast cancer
by: Suen Dacita, et al.
Published: (2008-07-01) -
Relationship of an hRAD54 gene polymorphism (2290 C/T) in an Ecuadorian population with chronic myelogenous leukemia
by: César Paz-y-Miño, et al.
Published: (2010-01-01) -
Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
by: Holly A. Rees, et al.
Published: (2019-05-01) -
"Tegan c.c.c.” and “Hrad Technika.” HBS Cases 609-038 and 609-039
by: Upton, D
Published: (2009) -
Candidate Tumor-Suppressor Gene DLEC1 Is Frequently Downregulated by Promoter Hypermethylation and Histone Hypoacetylation in Human Epithelial Ovarian Cancer
by: Joseph Kwong, et al.
Published: (2006-04-01)